Aicardi–Goutières Syndrome Type 2: A Report on Two Cases with Different Phenotypes Caused by RNASEH2B Gene Mutations

Abstract

Aicardi–Goutières syndrome (AGS) is a rare disorder characterized by acquired microcephaly, cerebral calcifications, leukodystrophy, cerebral atrophy, chronic lymphocytosis, and increased interferon-α in cerebrospinal fluid. We report on two children affected by AGS type 2, caused by mutations in RNASEH2B. The first child had the mutation c.529G > A (p.A177T) and presented with an atypical and mild phenotype, with delayed psychomotor development, calcifications of the brain white matter and basal ganglia, and interferon signature positivity. The disease course was stable. The second child presented the mutation c.554T > G (p.V185G) and showed a later onset (15 months) and a more progressive clinical course with functional inability in the upper limbs, steppage gait, and irritability. Despite immunoglobulin therapy, she developed to progressive tetraparesis and severe hypotonia. This case report highlights that RNASEH2B mutation cannot fully predict the phenotype of AGS type 2 when a mutation c.529G > A occurs. Moreover, an earlier symptomatology may be not related to a more severe prognosis or to a partial or absent response to treatment.

Keywords

Aicardi–Goutières syndrome - spastic paraparesis - type-I interferon - interferon signature - RNASEH2B

• References

• 1 Aicardi J, Goutières F. A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol 1984; 15 (01) 49-54
• 2 Lebon P, Badoual J, Ponsot G, Goutières F, Hémeury-Cukier F, Aicardi J. Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy. J Neurol Sci 1988; 84 (2,3): 201-208
• 3 Gardner RJ, Chow CW, Simpson I, Fink AM, Meagher SE, White SM. Severe fetal brain dysgenesis with focal calcification. Prenat Diagn 2005; 25 (05) 362-364
• 4 Livingston JH, Crow YJ. Neurologic phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi - Goutières syndrome and beyond. Neuropediatrics 2016; 47 (06) 355-360
• 5 Rice G, Patrick T, Parmar R. , et al. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet 2007; 81 (04) 713-725
• 6 C Uggetti, R La Piana, S Orcesi, M G Egitto, Y J Crow, E Fazzi. Aicardi Goutières syndrome: neuroradiologic findings and follow-up. 2009; 30 (10) 1971-1976
• 7 Crow YJ, Chase DS, Lowenstein Schmidt J. , et al. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am J Med Genet A 2015; 167A [phone]
• 8 Rice GI, Forte GM, Szynkiewicz M. , et al. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol 2013; 12 (12) 1159-1169
• 9 Fritz-French C, Tyor W. Interferon-α (IFNα) neurotoxicity. Cytokine Growth Factor Rev 2012; 23 (1–2): 7-14
• 10 Moscote-Salazar LR, Calderon-Miranda WG, Deluquez Baute RV. , et al. Aicardi-Goutières Syndrome: Brief Case Report. J Pediatr Neurosci 2018; 13 (01) 88-90
• 11 Tungler V, Schimdt F, Hieronimus S. Phenotypic variability in a family with Aicardi- Goutières syndrome due to the common A177T RNASEH2B mutation. Case Rep Clin Med 2014; 3: 153-156
• 12 Crow YJ, Leitch A, Hayward BE. , et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection. Nat Genet 2006; 38 (08) 910-916
• 13 Svingen L, Goheen M, Godfrey R. , et al. Late diagnosis and atypical brain imaging of Aicardi-Goutières syndrome: are we failing to diagnose Aicardi-Goutières syndrome-2?. Dev Med Child Neurol 2017; 59 (12) 1307-1311
• 14 Al Mutairi F, Alfadhel M, Nashabat M. , et al. Phenotypic and molecular spectrum of Aicardi-Goutières syndrome: a study of 24 patients. Pediatr Neurol 2018; 78: 35-40